PUBLISHER: IMARC | PRODUCT CODE: 1560947
PUBLISHER: IMARC | PRODUCT CODE: 1560947
The global urinary incontinence devices market size reached US$ 3.0 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.8 Billion by 2032, exhibiting a growth rate (CAGR) of 9.3% during 2024-2032. The growing occurrence of neurological diseases, diabetes, and obesity; increasing number of individuals who are addicted to smoking and alcohol consumption, and rising preference of patients to opt for minimally invasive (MI) treatment options represent some of the key factors driving the market.
Urinary incontinence devices are used by patients suffering from urinary incontinence leading to involuntary loss of urine. They comprise a wide variety of devices that work either by restricting the passage of urine or by changing the position of the bladder and urethra to control the bladder effectively. They also consist of various purpose-based devices for female patients, such as a pessary, which is a latex or silicon component that can be inserted into the vagina to treat stress incontinence and support the bladder. Urinary incontinence devices include an artificial urinary sphincter, which is a tiny device surgically implanted inside men to provide stress incontinence treatment. They are manufactured in various forms, such as donut and cube shapes, and must be fitted by a doctor. They are also produced in the form of small plugs, which are inserted into the urethra to prevent bladder leakage and are removed prior to urination. They are often paired with other incontinence treatments, such as Kegel exercises, medications, and specific bladder training.
At present, the increasing demand for urinary incontinence devices, as they are safe, reliable, and effective, represents one of the key factors supporting the market growth. Besides this, the rising occurrence of neurological diseases, diabetes, and obesity due to the adoption of unhealthy lifestyle habits and consumption of caffeine, sweeteners, chocolate, carbonated drinks, sparkling water, and muscle relaxants is propelling the growth of the market. In addition, the growing number of individuals who are addicted to smoking and alcohol consumption is offering a favorable market outlook. Apart from this, the rising occurrence of urinary incontinence among senior citizens is contributing to the growth of the market. Additionally, the increasing employment of at-home devices to treat stress, urge, and bowel incontinence is strengthening the growth of the market. Additionally, the rising preference of patients to opt for MI minimally invasive treatment options, as they reduce the duration of hospital stays and minimize postoperative scarring, is impelling the growth of the market. Moreover, the increasing awareness about the beneficial aspects of early diagnosis of urinary incontinence and the utilization of various electrical stimulation devices to manage the condition are bolstering the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global urinary incontinence devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, category, incontinence type, patient and end user.
The report has provided a detailed breakup and analysis of the urinary incontinence devices market based on the product. This includes urinary catheters, vaginal slings, electrical stimulation devices, artificial urinary sphincters, and others. According to the report, vaginal slings represented the largest segment.
A detailed breakup and analysis of the urinary incontinence devices market based on the category has also been provided in the report. This includes external urinary incontinence devices and internal urinary incontinence devices. According to the report, internal urinary incontinence devices accounted for the largest market share.
A detailed breakup and analysis of the urinary incontinence devices market based on the incontinence type has also been provided in the report. This includes stress urinary incontinence, urge urinary incontinence, overflow urinary incontinence, and mixed incontinence. According to the report, stress urinary incontinence accounted for the largest market share.
A detailed breakup and analysis of the urinary incontinence devices market based on the patient has also been provided in the report. This includes female and male. According to the report, female accounted for the largest market share.
A detailed breakup and analysis of the urinary incontinence devices market based on the end user has also been provided in the report. This includes hospitals, ambulatory surgical centers, and others. According to the report, hospitals accounted for the largest market share.
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America (the United States and Canada) was the largest market for urinary incontinence devices. Some of the factors driving the North America urinary incontinence devices market included the growing advancements in the healthcare sector, rising demand for minimally invasive (MI) medical procedures, increasing availability of favorable medical reimbursement policies, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global urinary incontinence devices market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include B. Braun Melsungen AG, Baxter International Inc, Becton Dickinson and Company, Boston Scientific Corporation, Caldera Medical Inc., Coloplast A/S, ConvaTec Group plc, Cook Group Inc., Johnson & Johnson, Kimberly-Clark Corporation, Laborie Medical Technologies Inc., Medtronic plc, Teleflex Incorporated, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.